-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Sj6VL/RzxNPIGC/DDz5dhh1dUGMlwc6uFZk5G7e5izjv8IEEniRNW/+uTly19Zu/ 1DyCOUJUGIGfAc//284slg== 0001193125-10-286088.txt : 20110218 0001193125-10-286088.hdr.sgml : 20110218 20101222080725 ACCESSION NUMBER: 0001193125-10-286088 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCH CHEMICALS INC CENTRAL INDEX KEY: 0001072343 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 061526315 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 501 MERRITT 7 STREET 2: P O BOX 4500 CITY: NORWALK STATE: CT ZIP: 06856-4500 BUSINESS PHONE: 2037503729 MAIL ADDRESS: STREET 1: 501 MERRITT 7 STREET 2: P O BOX 4500 CITY: NORWALK STATE: CT ZIP: 06856-4500 CORRESP 1 filename1.htm RESPONSE LETTER

ARCH CHEMICALS, INC.

501 Merritt Seven

Norwalk, Connecticut 06851

December 22, 2010

 

 

VIA EDGAR TRANSMISSION

Terence O’Brien

Branch Chief

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549-4631

 

Re:   

Arch Chemicals, Inc.

Form 10-K for the fiscal year ended December 31, 2009

Filed February 19, 2010

File No. 1-14601

Dear Mr. O’Brien:

Thank you for your letter dated December 13, 2010 in response to our letter of December 8, 2010 regarding the above-referenced matters. In reply to your comment, Arch Chemicals, Inc. (the “Company”) is providing the following response. For your convenience, our response follows your comment which is reproduced below.

Annual Report on Form 10-K filed on February 19, 2010

Exhibits, page 113

 

  1. We note your response to comment one in our letter dated November 23, 2010 and reissue this comment. In this regard, we note that Item 601(b)(10) does not permit exclusion of these exhibits or schedules. If you believe there is competitively sensitive information in the exhibits or schedules, you may file an application for confidential treatment pursuant to Rule 24b-2 under the Exchange Act, which sets forth the exclusive means for obtaining confidential treatment of information contained in a document filed under the Exchange Act. Please also refer to Staff Legal Bulletins No. 1 and 1A, dated February 28, 1997 and July 11, 2001, respectively, which set forth the Division of Corporation Finance’s views regarding the proper preparation of a request for confidential treatment.

RESPONSE:

The Company will comply with your request to file the omitted exhibits and schedules as amendments to our Form 8-Ks promptly but no later than January 7, 2011.

 

Very truly yours,
/s/ Steven C. Giuliano        

Steven C. Giuliano

Senior Vice President and

Chief Financial Officer

 -----END PRIVACY-ENHANCED MESSAGE-----